Citation: M. Mcloughlin et al., AQUEOUS STABILITY OF SB-210661 - KINETICS AND PRIMARY DEGRADATION MECHANISMS OF AN N-HYDROXYUREA-CONTAINING 5-LIPOXYGENASE INHIBITOR, Journal of Pharmacy and Pharmacology, 50(2), 1998, pp. 127-132
Citation: K. Patel et al., INVESTIGATION OF NEW DEGRADATION PRODUCTS ARISING FROM THE ENCAPSULATION OF AN OIL-BASED SUSPENSION FORMULATION OF TOPOTECAN, International journal of pharmaceutics, 151(1), 1997, pp. 7-13
Citation: As. Kearney et al., PREFORMULATION STUDIES TO AID IN THE DEVELOPMENT OF A READY-TO-USE INJECTABLE SOLUTION OF THE ANTITUMOR AGENT, TOPOTECAN, International journal of pharmaceutics, 127(2), 1996, pp. 229-237
Authors:
KEARNEY AS
GABRIEL DL
MEHTA SC
RADEBAUGH GW
Citation: As. Kearney et al., EFFECT OF POLYVINYLPYRROLIDONE ON THE CRYSTALLINITY AND DISSOLUTION RATE OF SOLID DISPERSIONS OF THE ANTIINFLAMMATORY CI-987, International journal of pharmaceutics, 104(2), 1994, pp. 169-174
Citation: As. Kearney et al., PREFORMULATION STUDIES TO AID IN THE DEVELOPMENT OF AN INJECTABLE FORMULATION OF PD-144872, A RADIOSENSITIZING ANTICANCER AGENT, International journal of pharmaceutics, 102(1-3), 1994, pp. 63-70
Authors:
KEARNEY AS
CRAWFORD LF
MEHTA SC
RADEBAUGH GW
Citation: As. Kearney et al., THE INTERCONVERSION KINETICS, EQUILIBRIUM, AND SOLUBILITIES OF THE LACTONE AND HYDROXYACID FORMS OF THE HMG-COA REDUCTASE INHIBITOR, CI-981, Pharmaceutical research, 10(10), 1993, pp. 1461-1465
Citation: As. Kearney et al., THE EFFECT OF STRUCTURAL-CHANGES ON THE INTRAMOLECULAR DEGRADATION OFTHE DIPEPTOID CI-988, International journal of pharmaceutics, 92(1-3), 1993, pp. 63-70